Recent News
Talcum Powder Class Action Lawsuit Filed in Canada
Johnson & Johnson continues to face mounting lawsuits over the alleged link between its talcum powder products and ovarian cancer. According to a report from CTV New, a class action was recently filed in Toronto, Ontario on behalf of Canadian … Continue reading
Taxotere Hair Loss Litigation Grows, With New Lawsuits Filed in Texas and Mississippi
The litigation involving Taxotere and permanent alopecia continues to grow, with new filing reported in Texas and Mississippi. Like other cases pending around the country, these complaints claim that Sanofi-Aventis failed to warn patients and doctors that hair loss associated … Continue reading
FDA Says Invokana May Be Linked to Amputations
The U.S. Food & Drug Administration (FDA) warned this week that canagliflozin, an active ingredient in Invokana and Invokamet, may be associated with an increased risk of foot and leg amputations, especially those affecting the toes. While the agency has … Continue reading
Nexium, Other Proton Pump Inhibitors May Harm Blood Vessels.
Yet another study is raising questions about the long-term safety of Nexium and other proton pump inhibitors. This time, scientists with the Houston Methodist Research Institute are reporting that use of the popular heart burn drugs could cause blood vessels … Continue reading
FDA Strengthens Warnings for Levaquin, Other Fluoroquinolone Antibiotics
Federal health regulators are warning that Levaquin and other antibiotics called fluoroquinolones may cause a number of serious complications, including muscle and nerve damage. The U.S. Food & Drug Administration (FDA) is now advising that the use of these medications … Continue reading
More Talcum Powder Lawsuit Filings Expected Following $55 Million Johnson & Johnson Verdict
Johnson & Johnson is expected to face more talcum powder ovarian cancer claims, following a stunning defeat in the latest such lawsuit to go to trial. The verdict, which was rendered last month in Missouri state court, marked the second … Continue reading
FDA Issues New Warning for Abilify Gambling, Other Compulsive Behaviors
U.S. health regulators have issued a new alert regarding the potential for Abilify to cause compulsive gambling and other impulse control issues. The drug’s label, along with the labels for Abilify Maintena and Aristada, will be modified with stronger warnings … Continue reading
Levaquin Lawsuit Update: Initial Case Management Plan Issued in Federal Fluoroquinolone Litigation
The federal court overseeing hundreds of lawsuits involving fluoroquinolone antibiotics and peripheral neuropathy has issued the multidistrict litigation’s Initial Case Management Plan. Among other things, the document set sforth protocols and limitations for discovery during the early stages of the … Continue reading
Could Nexium Put Seniors at Greater Risk for Dementia?
Seniors who take Nexium and other proton pump inhibitors may face an increased risk of dementia, according to a recently-published study. The research is just the latest to suggest that overuse of the popular heartburn medications could have a serious … Continue reading
Breast Cancer Survivor Blames Taxotere for Ongoing Hair Loss Problem
Drug maker Sanofi-Aventis has been hit with yet another Taxotere lawsuit, this time in Colorado. Like other legal cases involving the chemotherapy medication, this complaint claims that Sanofi-Aventis concealed information about the drug’s association with permanent alopecia (hair loss). Brought … Continue reading
Follow Us
